Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Mallinckrodt
Merck
Boehringer Ingelheim
Express Scripts

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE

See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Naloxone Hydrochloride; Oxycodone Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00412100 Oxycodone-naloxone Prolonged Release Tablets in Relieving Opioid-related Constipation Completed Mundipharma Research GmbH & Co KG Phase 3 2006-04-01 The primary objective is to demonstrate that patients taking oxycodone/naloxone prolonged release tablets have improvement in symptoms of constipation compared to subjects taking oxycodone prolonged release tablets alone.
NCT00412152 Oxycodone-naloxone in Relieving Opioid-related Constipation Completed Mundipharma Research GmbH & Co KG Phase 3 2006-01-01 The primary objective of this study is to demonstrate that subjects with moderate to severe non-malignant pain taking oxycodone/naloxone prolonged release tablets have improvement in symptoms of constipation compared to subjects taking oxycodone prolonged release tablets alone.
NCT00513656 A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain Completed Mundipharma Research GmbH & Co KG Phase 2 2007-09-01 The purpose of this study is to test the oxycodone/naloxone combination compared to oxycodone alone in patient's specific type of "chronic cancer pain".
NCT00784810 A Study to Compare Oxycodone/Naloxone Prolonged Release Against Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis Completed Napp Pharmaceuticals Limited Phase 4 2009-02-01 The purpose of this study is to compare oxycodone/naloxone combination tablet and codeine/paracetamol tablets in the treatment of moderate to severe chronic low back pain or pain due to osteoarthritis.
NCT00902837 OXN PR Compared to OxyPR to Demonstrate Non-inferiority in Pain & Locomotor Function & Improvement in Symptoms of Constipation in OA Subjects Completed Mundipharma Research GmbH & Co KG Phase 3 2009-05-01 The primary objectives are - to demonstrate that the treatment with OXN PR tablets is non-inferior to the treatment with OxyPR with regards to analgesic efficacy and locomotor function. - to demonstrate that subjects with moderate to severe OA pain taking oxycodone/naloxone prolonged release tablets have improvement in symptoms of constipation compared to subjects taking oxycodone prolonged release tablets alone
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Naloxone Hydrochloride; Oxycodone Hydrochloride

Condition Name

Condition Name for Naloxone Hydrochloride; Oxycodone Hydrochloride
Intervention Trials
Pain 9
Low Back Pain 6
Constipation 5
Cancer 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Naloxone Hydrochloride; Oxycodone Hydrochloride
Intervention Trials
Constipation 11
Low Back Pain 7
Back Pain 7
Pain, Postoperative 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Naloxone Hydrochloride; Oxycodone Hydrochloride

Trials by Country

Trials by Country for Naloxone Hydrochloride; Oxycodone Hydrochloride
Location Trials
United States 115
China 18
Germany 7
United Kingdom 6
Korea, Republic of 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Naloxone Hydrochloride; Oxycodone Hydrochloride
Location Trials
New York 6
Virginia 4
North Carolina 4
Texas 4
Utah 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Naloxone Hydrochloride; Oxycodone Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Naloxone Hydrochloride; Oxycodone Hydrochloride
Clinical Trial Phase Trials
Phase 4 17
Phase 3 17
Phase 2/Phase 3 1
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Naloxone Hydrochloride; Oxycodone Hydrochloride
Clinical Trial Phase Trials
Completed 32
Recruiting 5
Unknown status 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Naloxone Hydrochloride; Oxycodone Hydrochloride

Sponsor Name

Sponsor Name for Naloxone Hydrochloride; Oxycodone Hydrochloride
Sponsor Trials
Mundipharma Research GmbH & Co KG 11
Mundipharma Korea Ltd 5
Purdue Pharma LP 4
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Naloxone Hydrochloride; Oxycodone Hydrochloride
Sponsor Trials
Industry 36
Other 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Medtronic
Baxter
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.